S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

IGM Biosciences (IGMS) Earnings Date, Estimates & Call Transcripts

$7.41
-0.72 (-8.86%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 10Estimated
Actual EPS
(Mar. 7)
-$1.01 Beat By $0.05
Consensus EPS
(Mar. 7)
-$1.06
Skip Charts & View Estimated and Actual Earnings Data

IGMS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IGMS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IGM Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.81)($0.75)($0.78) 
Q2 20242($0.79)($0.76)($0.78) 
Q3 20242($0.82)($0.76)($0.79) 
Q4 20242($1.20)($0.84)($1.02) 
FY 20248($3.62)($3.11) ($3.37)

IGMS Earnings Date and Information

IGM Biosciences last announced its quarterly earnings data on March 7th, 2024. The reported ($1.01) EPS for the quarter, beating the consensus estimate of ($1.06) by $0.05. The firm earned $0.65 million during the quarter, compared to the consensus estimate of $0.95 million. IGM Biosciences has generated ($4.81) earnings per share over the last year (($4.81) diluted earnings per share). Earnings for IGM Biosciences are expected to grow in the coming year, from ($3.23) to ($3.03) per share. IGM Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

IGM Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
3/7/2024Q4 2023($1.06)($1.01)+$0.05($1.01)$0.95 million$0.65 million
11/13/2023Q3 2023($1.25)($1.04)+$0.21($1.04)$0.73 million$0.51 million
8/3/2023Q2 2023($1.40)($1.43)($0.03)($1.43)$0.80 million$0.45 million
5/12/2023Q1 2023($1.37)($1.33)+$0.04($1.33)$1.79 million$0.52 million
3/30/2023Q4 2022($1.53)($1.19)+$0.34($1.19)$15.27 million$0.37 million    
11/3/2022Q3 2022($1.45)($1.32)+$0.13($1.32)$0.39 million$0.33 million
8/8/2022Q2 2022($1.44)($1.33)+$0.11($1.33)$38.91 million$0.37 million
5/9/2022Q1 2022($1.65)($1.53)+$0.12($1.53)--
3/29/2022Q4 2021($1.58)($1.50)+$0.08($1.50)--
11/4/2021Q3 2021($1.33)($1.32)+$0.01($1.32)--
8/8/2021Q2 2021($1.16)($1.16)-($1.16)--
5/6/2021Q1 2021($0.98)($0.95)+$0.03($0.95)--  

IGM Biosciences Earnings - Frequently Asked Questions

When is IGM Biosciences's earnings date?

IGM Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on IGMS's earnings history.

Did IGM Biosciences beat their earnings estimates last quarter?

In the previous quarter, IGM Biosciences (NASDAQ:IGMS) reported ($1.01) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.06) by $0.05. Learn more on analysts' earnings estimate vs. IGMS's actual earnings.

How much revenue does IGM Biosciences generate each year?

IGM Biosciences (NASDAQ:IGMS) has a recorded annual revenue of $2.13 million.

How much profit does IGM Biosciences generate each year?

IGM Biosciences (NASDAQ:IGMS) has a recorded net income of -$246.42 million. IGMS has generated -$4.81 earnings per share over the last four quarters.

What is IGM Biosciences's EPS forecast for next year?

IGM Biosciences's earnings are expected to grow from ($3.23) per share to ($3.03) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:IGMS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners